BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30598409)

  • 1. Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation.
    Gomes CC; de Sousa SF; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Mar; 127(3):231-236. PubMed ID: 30598409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases.
    Paulus W; Stöckel C; Krauss J; Sörensen N; Roggendorf W
    Histopathology; 1997 Feb; 30(2):172-6. PubMed ID: 9067743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
    Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
    Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC
    J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniopharyngioma in Pediatrics and Adults.
    Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
    Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
    Brastianos PK; Taylor-Weiner A; Manley PE; Jones RT; Dias-Santagata D; Thorner AR; Lawrence MS; Rodriguez FJ; Bernardo LA; Schubert L; Sunkavalli A; Shillingford N; Calicchio ML; Lidov HG; Taha H; Martinez-Lage M; Santi M; Storm PB; Lee JY; Palmer JN; Adappa ND; Scott RM; Dunn IF; Laws ER; Stewart C; Ligon KL; Hoang MP; Van Hummelen P; Hahn WC; Louis DN; Resnick AC; Kieran MW; Getz G; Santagata S
    Nat Genet; 2014 Feb; 46(2):161-5. PubMed ID: 24413733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.
    Cani CM; Matushita H; Carvalho LR; Soares IC; Brito LP; Almeida MQ; Mendonça BB
    Clinics (Sao Paulo); 2011; 66(11):1849-54. PubMed ID: 22086512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
    J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal.
    Bernstein ML; Buchino JJ
    Oral Surg Oral Med Oral Pathol; 1983 Nov; 56(5):502-11. PubMed ID: 6196702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma].
    Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.
    Oikonomou E; Barreto DC; Soares B; De Marco L; Buchfelder M; Adams EF
    J Neurooncol; 2005 Jul; 73(3):205-9. PubMed ID: 15980970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
    Goschzik T; Gessi M; Dreschmann V; Gebhardt U; Wang L; Yamaguchi S; Wheeler DA; Lauriola L; Lau CC; Müller HL; Pietsch T
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):126-134. PubMed ID: 28069929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.
    Campanini ML; Colli LM; Paixao BM; Cabral TP; Amaral FC; Machado HR; Neder LS; Saggioro F; Moreira AC; Antonini SR; de Castro M
    Horm Cancer; 2010 Aug; 1(4):187-96. PubMed ID: 21761366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
    Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
    Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
    Robinson LC; Santagata S; Hankinson TC
    Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghost cells in pilomatrixoma, craniopharyngioma, and calcifying cystic odontogenic tumor: histological, immunohistochemical, and ultrastructural study.
    Rumayor A; Carlos R; Kirsch HM; de Andrade BA; Romañach MJ; de Almeida OP
    J Oral Pathol Med; 2015 Apr; 44(4):284-90. PubMed ID: 25047924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
    Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
    Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
    Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
    Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular pathogenesis of craniopharyngiomas.
    Campanini ML; Almeida JP; Martins CS; de Castro M
    Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation.
    Sekine S; Takata T; Shibata T; Mori M; Morishita Y; Noguchi M; Uchida T; Kanai Y; Hirohashi S
    Histopathology; 2004 Dec; 45(6):573-9. PubMed ID: 15569047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.